Gulsin, Gaurav S.

Risk Factors for Nonadherence to Antihypertensive Treatment

Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C. M. J., Petrák, O., Gulsin, G. S., Patel, V., et al. (2017) · Hypertension

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 256

Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence

Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Gulsin, G. S., Beech, A., Marešová, V., Topham, P. S., Stanley, A., et al. (2017) · Hypertension

Medication Adherence and ComplianceBlood Pressure and Hypertension Studies

Cited by 194

Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure with Preserved Ejection Fraction

Kanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging

Cardiac Imaging and DiagnosticsCardiomyopathy and Myosin Studies

Cited by 126

Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial

Ahmad, E., Waller, H. L., Sargeant, J. A., Webb, M. A., Htike, Z. Z., McCann, G. P., Gulsin, G., Khunti, K., Yates, T., Henson, J., et al. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 27

Initiation of New Glucose-Lowering Therapies May Act to Reduce Physical Activity Levels: Pooled Analysis From Three Randomized Trials

Yates, T., Sargeant, J. A., King, J. A., Henson, J., Edwardson, C. L., Redman, E., Gulsin, G. S., Brady, E. M., Ahmad, E., Stensel, D. J., et al. (2022) · Diabetes Care

Diabetes Treatment and ManagementPhysical Activity and Health

Cited by 9